Target intelligence / Profile preview

Damaged brain receptors

Molecular classification
Other
01

Overview

The term "Damaged brain receptors" is a descriptive phrase rather than a specific molecular target. It refers to a pathological state where various neurotransmitter receptors, such as NMDA, AMPA, or G-protein coupled receptors, undergo structural or functional impairment due to disease or injury. This damage often results from processes like excitotoxicity, oxidative stress, or protein misfolding, which are hallmark features of neurodegenerative diseases and traumatic brain injury (PubMed: 30206104). Because the term encompasses a wide array of distinct protein families and mechanisms, it lacks the specificity required for a canonical therapeutic target. In clinical research, specific receptors are targeted to mitigate the consequences of this damage, such as using NMDA receptor antagonists to prevent further excitotoxic injury (StatPearls: NBK507757).

Other names
Dysfunctional brain receptorsImpaired neural receptorsDegraded neurotransmitter receptors
02

Mechanism of action

Not applicable as this is a descriptive state of multiple potential targets rather than a single entity.

03

Biological functions

Signal transductionNeurotransmissionSynaptic plasticity
04

Disease associations

Neurodegenerative diseaseTraumatic brain injuryStrokeExcitotoxicityAlzheimer's disease
05

Safety considerations

Lack of molecular specificityDifficulty in distinguishing between damaged and healthy receptor populationsPotential for widespread off-target effects
06

Biomarkers

Neurofilament light chain (NfL)Glial fibrillary acidic protein (GFAP)Ubiquitin C-terminal hydrolase L1 (UCH-L1)Tau protein levels

Beyond the preview

Go deeper on Damaged brain receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damaged brain receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call